Paper8097524
Recombinant interleukin 12 cures mice infected with Leishmania major.
Heinzel FP and 4 others. J Exp Med, 1993. Cited by 734 papers, by iCite.
Cite this record
ConductScience Library. Recombinant interleukin 12 cures mice infected with Leishmania major. Papers, record 8097524. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8097524
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukins | Major topic |
| Leishmaniasis, Cutaneous | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| Interferon-gamma | |
| Interleukin-12 | |
| Leishmania tropica | |
| Lymph Nodes | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C57BL | |
| Recombinant Proteins | |
| Spleen | |
| T-Lymphocytes |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AI-27461 | NIAID NIH HHS | United States | R29AI027461 | PubMed and NIH |
Source NIH RePORTER
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3926895 | Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. | J Immunol | 1985 | https://conductscience.org/library/papers/3926895 | PubMed |
| 2 | 1358972 | Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells. | J Immunol | 1992 | https://conductscience.org/library/papers/1358972 | PubMed |
| 3 | 3782864 | New perspectives on a subclinical form of visceral leishmaniasis. | J Infect Dis | 1986 | https://conductscience.org/library/papers/3782864 | PubMed |
| 4 | 2903212 | Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. | J Exp Med | 1988 | https://conductscience.org/library/papers/2903212 | PubMed |
| 5 | 2521244 | Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. | J Exp Med | 1989 | https://conductscience.org/library/papers/2521244 | PubMed |
| 6 | 2492265 | Endotoxin-induced serum factor that stimulates gamma interferon production. | Infect Immun | 1989 | https://conductscience.org/library/papers/2492265 | PubMed |
| 7 | 2522884 | The role of TH1 and TH2 cells in experimental cutaneous leishmaniasis. | Exp Parasitol | 1989 | https://conductscience.org/library/papers/2522884 | PubMed |
| 8 | 2499629 | Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. | J Immunol | 1989 | https://conductscience.org/library/papers/2499629 | PubMed |
| 9 | 2509562 | IL-4 inhibits H2O2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-gamma. | J Immunol | 1989 | https://conductscience.org/library/papers/2509562 | PubMed |
| 10 | 2104918 | Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. | J Exp Med | 1990 | https://conductscience.org/library/papers/2104918 | PubMed |
| 11 | 1672545 | Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. | J Exp Med | 1991 | https://conductscience.org/library/papers/1672545 | PubMed |
| 12 | 1831830 | Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines. | J Immunol | 1991 | https://conductscience.org/library/papers/1831830 | PubMed |
| 13 | 1717284 | A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. | Eur J Immunol | 1991 | https://conductscience.org/library/papers/1717284 | PubMed |
| 14 | 1684779 | Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. | Immunol Rev | 1991 | https://conductscience.org/library/papers/1684779 | PubMed |
| 15 | 1531351 | IL-4 induces a Th2 response in Leishmania major-infected mice. | J Immunol | 1992 | https://conductscience.org/library/papers/1531351 | PubMed |
| 16 | 1350290 | Cloning and expression of murine IL-12. | J Immunol | 1992 | https://conductscience.org/library/papers/1350290 | PubMed |
| 17 | 3079789 | Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro. | J Immunol | 1986 | https://conductscience.org/library/papers/3079789 | PubMed |
Cited by197
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 734 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40732663 | Immune-Pathological Correlates of Disease Severity in New-World Kala-Azar: The Role of Parasite Load and Cytokine Profiles. | Pathogens | 2025 | https://conductscience.org/library/papers/40732663 | PubMed |
| 40512023 | Oxygen and immunity to Leishmania infection. | Infect Immun | 2025 | https://conductscience.org/library/papers/40512023 | PubMed |
| 40287829 | An overview of host immune responses against Leishmania spp. infections. | Hum Mol Genet | 2025 | https://conductscience.org/library/papers/40287829 | PubMed |
| 38543472 | New Approaches to Tackling Intractable Issues in Infectious Disease. | Microorganisms | 2024 | https://conductscience.org/library/papers/38543472 | PubMed |
| 37885890 | Leishmania major-derived lipophosphoglycan influences the host's early immune response by inducing platelet activation and DKK1 production via TLR1/2. | Front Immunol | 2023 | https://conductscience.org/library/papers/37885890 | PubMed |
| 36579347 | Humoral response in Leishmaniasis. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/36579347 | PubMed |
| 36365010 | Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial Designs. | Pathogens | 2022 | https://conductscience.org/library/papers/36365010 | PubMed |
| 35025891 | A profile of research on the parasitic trypanosomatids and the diseases they cause. | PLoS Negl Trop Dis | 2022 | https://conductscience.org/library/papers/35025891 | PubMed |
| 34684248 | Revisiting Persistent Salmonella Infection and the Carrier State: What Do We Know? | Pathogens | 2021 | https://conductscience.org/library/papers/34684248 | PubMed |
| 33934238 | Potential biomarkers of immune protection in human leishmaniasis. | Med Microbiol Immunol | 2021 | https://conductscience.org/library/papers/33934238 | PubMed |
| 33841444 | Host-Directed Therapies for Cutaneous Leishmaniasis. | Front Immunol | 2021 | https://conductscience.org/library/papers/33841444 | PubMed |
| 33604564 | Humoral immunity in leishmaniasis - Prevention or promotion of parasite growth? | Cytokine X | 2020 | https://conductscience.org/library/papers/33604564 | PubMed |
| 33415318 | Unravelling the unsolved paradoxes of cytokine families in host resistance and susceptibility to Leishmania infection. | Cytokine X | 2020 | https://conductscience.org/library/papers/33415318 | PubMed |
| 32948646 | Acute IL-4 Governs Pathogenic T Cell Responses during Leishmania major Infection. | Immunohorizons | 2020 | https://conductscience.org/library/papers/32948646 | PubMed |
| 32784615 | Leishmania Immunity: Advancing Immunotherapy and Vaccine Development. | Microorganisms | 2020 | https://conductscience.org/library/papers/32784615 | PubMed |
| 31024534 | Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy. | Front Immunol | 2019 | https://conductscience.org/library/papers/31024534 | PubMed |
| 30697312 | Effects of Cytokine Therapy for Treatment and Prophylaxis of Hydatidosis in Experimental Animal Model (Mice). | Iran J Parasitol | 2018 | https://conductscience.org/library/papers/30697312 | PubMed |
| 30257371 | Monocyte subpopulations as important biomarkers of resistence and susceptibility during experimental infection with Leishmania (Leishmania) major. | Biomed Pharmacother | 2018 | https://conductscience.org/library/papers/30257371 | PubMed |
| 29867798 | Leishmania Hijacks Myeloid Cells for Immune Escape. | Front Microbiol | 2018 | https://conductscience.org/library/papers/29867798 | PubMed |
| 29593739 | STAT6 Mediates Footpad Immunopathology in the Absence of IL-12p40 Following Infection of Susceptible BALB/c Mice With Leishmania major. | Front Immunol | 2018 | https://conductscience.org/library/papers/29593739 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8097524
GET https://conductscience.org/api/papers/v1/8097524/cited_by?page=2